A prospective study of health related quality of life, bowel and sexual function after TaTME and conventional laparoscopic TME for mid and low rectal cancer
Tóm tắt
The aim of our study was to evaluate short -term (3 months) and medium-term (12 months) postoperative effects on health related quality of life (HRQoL), bowel and sexual function after transanal total mesorectal excision (TaTME) in comparison with conventional laparoscopic total mesorectal excision (TME). A prospective study was conducted on consecutive patients who had conventional laparoscopic TME and TaTME at our institution from November 2014 to December 2018.We evaluated HRQoL and bowel function using validated scales including the European Organization for Research and Treatment of Cancer Quality of Life of colorectal cancer specific module (EORTC-QLQ-CR29), International Index of Erectile Function (IIEF-5), Female Sexual Function Index (FSFI), low anterior resection syndrome (LARS) score and Wexner score. Patients were matched one-to-one through propensity score matching. Outcomes of the questionnaires at 3 and 12 months were compared. Sixty patients were enrolled in the study. There were 30 in the conventional laparoscopic group (13 males; median age 69.3 years [range 35–80 years]) and 30 in the TaTME group (14 males; median age 75.6 years [range 42–83 years]). Three months after ileostmy closure, patients in the TaTME group had significantly more buttock pain (p = 0.030), bloating (p = 0.023), stool frequency (p = 0.013), flatulence (p < 0.001) and fecal incontinence (p = 0.044), although none of these differences persisted at 12 months. Patients in the TaTME group had a higher median overall LARS score at 3 months (p = 0.032) but there was no difference at 12 months. At 12 months after TaTME female patients had better women’s sexual interest (p = 0.039) and dyspareunia scores (p < 0.001), while male patients had better erectile function (p = 0.038). Other scales did not reveal a significant difference at either 3 of 12 months between groups. Compared with patients with mid and low rectal cancer treated with conventional laparoscopic TME, those treated with TaTME have worse HRQoL and bowel function for a short period after primary resection, but seem to have better sexual function in the long term.
Tài liệu tham khảo
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69(10):613–616. https://doi.org/10.1002/bjs.1800691019
Kneist W, Hanke L, Kauff DW, Lang H (2016) Surgeons’ assessment of internal anal sphincter nerve supply during TaTME - inbetween expectations and reality. MITAT Off J Soc Minimally Invasive Therapy 25(5):241–246. https://doi.org/10.1080/13645706.2016.1197269
Chouillard E, Regnier A, Vitte RL, Bonnet BV, Greco V, Chahine E, Daher R, Biagini J (2016) Transanal NOTES total mesorectal excision (TME) in patients with rectal cancer: is anatomy better preserved? Tech Coloproctol 20(8):537–544. https://doi.org/10.1007/s10151-016-1449-z
Lacy AM, Adelsdorfer C, Delgado S, Sylla P, Rattner DW (2013) Minilaparoscopy-assisted transrectal low anterior resection (LAR): a preliminary study. Surg Endosc 27(1):339–346. https://doi.org/10.1007/s00464-012-2443-9
Velthuis S, van den Boezem PB, van der Peet DL, Cuesta MA, Sietses C (2013) Feasibility study of transanal total mesorectal excision. Br J Surg 100(6):828–831. https://doi.org/10.1002/bjs.9069
Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, Castells A, Bravo R, Wexner SD, Heald RJ (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am CollSurg 221(2):415–423. https://doi.org/10.1016/j.jamcollsurg.2015.03.046
Larsen, S. G., Pfeffer, F., Kørner, H., AND Norwegian Colorectal Cancer Group (2019) Norwegian moratorium on transanal total mesorectal excision. Br J Surg 106(9):1120–1121. https://doi.org/10.1002/bjs.11287
Di Fabio F, Koller M, Nascimbeni R, Talarico C, Salerni B (2008) Long-term outcome after colorectal cancer resection. Patients’ self-reported quality of life, sexual dysfunction and surgeons’ awareness of patients’ needs. Tumori 94(1):30–35
Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP (2016) A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis Off J AssocColoproctol Great Br Ireland 18(1):19–36. https://doi.org/10.1111/codi.13151
Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ (2017) Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Surg Endosc 31(12):5248–5257. https://doi.org/10.1007/s00464-017-5597-7
Lee L, Kelly J, Nassif GJ, deBeche-Adams TC, Albert MR, Monson J (2020) Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma. Surg Endosc 34(4):1534–1542. https://doi.org/10.1007/s00464-018-6360-4
Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255(5):922–928. https://doi.org/10.1097/SLA.0b013e31824f1c21
Kupsch J, Jackisch T, Matzel KE, Zimmer J, Schreiber A, Sims A, Witzigmann H, Stelzner S (2018) Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score. Int J Colorectal Dis 33(6):787–798. https://doi.org/10.1007/s00384-018-3006-x
Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, Sylvester P, Koller M, Sprangers MA, Blazeby JM, European Organisation for Research and Treatment of Cancer Quality of Life Group (2007) Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer (Oxford, England: 1990) 43(10):1564–1573. https://doi.org/10.1016/j.ejca.2007.04.005
Whistance, R. N., Conroy, T., Chie, W., Costantini, A., Sezer, O., Koller, M., Johnson, C. D., Pilkington, S. A., Arraras, J., Ben-Josef, E., Pullyblank, A. M., Fayers, P., Blazeby, J. M., European Organisation for the Research and Treatment of Cancer Quality of Life Group (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45(17):3017–3026. https://doi.org/10.1016/j.ejca.2009.08.014
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208. https://doi.org/10.1080/009262300278597
Kretschmer A, Bischoff R, Chaloupka M, Jokisch F, Westhofen T, Weinhold P, Strittmatter F, Becker A, Buchner A, Stief CG (2020) Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis. World J Urol. https://doi.org/10.1007/s00345-020-03144-9
Croese AD, Lonie JM, Trollope AF, Vangaveti VN, Ho YH (2018) A meta-analysis of the prevalence of Low Anterior Resection Syndrome and systematic review of risk factors. Internat J Surg (London, England) 56:234–241. https://doi.org/10.1016/j.ijsu.2018.06.031
Pucciani F (2018) Post-surgical fecal incontinence. Updates Surg 70(4):477–484. https://doi.org/10.1007/s13304-017-0508-y
Wallner, C., Lange, M. M., Bonsing, B. A., Maas, C. P., Wallace, C. N., Dabhoiwala, N. F., Rutten, H. J., Lamers, W. H., Deruiter, M. C., van de Velde, C. J., Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial (2008) Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. J ClinOncol Off Am SocClinOncol 26(27):4466–4472. https://doi.org/10.1200/JCO.2008.17.3062
Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL (2012) Anterior resection syndrome. Lancet Oncol 13(9):e403–e408. https://doi.org/10.1016/S1470-2045(12)70236-X
Simillis C, Lal N, Thoukididou SN, Kontovounisios C, Smith JJ, Hompes R, Adamina M, Tekkis PP (2019) Open versus laparoscopic versus robotic versus transanalmesorectal excision for rectal cancer: a systematic review and network meta-analysis. Ann Surg 270(1):59–68. https://doi.org/10.1097/SLA.0000000000003227
Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ (2016) COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 30(8):3210–3215. https://doi.org/10.1007/s00464-015-4615-x
Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, Liu H, Wang Z (2016) Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC cancer 16:380. https://doi.org/10.1186/s12885-016-2428-5
Jiang HP, Li YS, Wang B, Wang C, Liu F, Shen ZL, Ye YJ, Wang S (2018) Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis. Surg Endosc 32(6):2632–2642. https://doi.org/10.1007/s00464-018-6103-6
Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, Rullier E (2016) Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surg Endosc 30(11):4924–4933. https://doi.org/10.1007/s00464-016-4833-x
Rouanet P, Bertrand MM, Jarlier M, Mourregot A, Traore D, Taoum C, de Forges H, Colombo PE (2018) Robotic versus laparoscopic total mesorectal excision for sphincter-saving surgery: results of a single-center series of 400 consecutive patients and perspectives. Ann SurgOncol 25(12):3572–3579. https://doi.org/10.1245/s10434-018-6738-5
Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G, Delpero JR, Hanoun L, Michot F (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261(2):228–233. https://doi.org/10.1097/SLA.0000000000000994
Elmore U, Fumagalli Romario U, Vignali A, Sosa MF, Angiolini MR, Rosati R (2015) Laparoscopic anterior resection with transanal total mesorectal excision for rectal cancer: preliminary experience and impact on postoperative bowel function. J LaparoendosAdvSurg Tech Part A 25(5):364–369. https://doi.org/10.1089/lap.2014.0435
Hanke LI, Kauff DW, Lang H, Kneist W (2017) Ano (neo-)rectal function after transanal total mesorectal excision (TaTME) for primary rectal cancer. German SocSurg (DGCH) 12:18–23
Lin JB, Zhang L et al (2017) Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer. World J Gastroenterol 23(10):1891–1898. https://doi.org/10.3748/wjg.v23.i10.1891
Veltcamp Helbach M, Koedam T, Knol JJ, Diederik A, Spaargaren GJ, Bonjer HJ, Tuynman JB, Sietses C (2019) Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surg Endosc 33(1):94–102. https://doi.org/10.1007/s00464-018-6279-9
Keller DS, Reali C, Spinelli A, Penna M, Di Candido F, Cunningham C, Hompes R (2019) Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision. Br J Surg 106(4):364–366. https://doi.org/10.1002/bjs.11069
Turrado-Rodriguez V, Torroella AT, de Lacy OF, Guarner Piquet P, Otero-Pineiro A, Martin-Perez B et al (2018) Functional outcomes after TaTME: retrospective analysis of quality of life and pelvic function. Dis Colon Rectum 61(5):E222–E238
Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J GastrointestSurgOff J SocSurg Aliment Tract 23(8):1623–1630. https://doi.org/10.1007/s11605-018-4057-6